Alzheimer's Lecture Highlights New Treatment, Diagnostics

The latest in Alzheimer's research will be presented at the 2023 Update on Alzheimer's Disease lecture presented by Baylor College of Medicine and the Alzheimer's Association® Houston & Southeast Texas Chapter.

The event will be held Nov. 13 at 7 p.m. at the Hope & Healing Center at St. Martin's Episcopal Church, 717 Sage Rd. It is free to attend in person or virtually.

Dr. Melissa Yu, director of the Alzheimer's Disease and Memory Disorders Center (ADMDC) at Baylor Medicine, and Dr. Roy Lin, assistant professor of neurology at Baylor, will discuss the basics of Alzheimer's disease, current therapies, new approaches and the latest in new research that could lead to promising new treatments.

"There have been exciting new developments in Alzheimer's disease since last year's talk, including the first medication approved by the FDA to delay progression of Alzheimer's disease and new tests to aid in making a more definitive diagnosis," Yu said. "Early detection of the disease is becoming more critical for identifying people who may benefit from the new diagnostic and therapeutic tools."

Alzheimer's and dementia currently affect an estimated 6 million Americans and are the sixth leading cause of death among Americans. Dementia hits close to home, too; an estimated 400,000 Texans are currently living with dementia or Alzheimer's.

"At the Alzheimer's Association, we envision a world without Alzheimer's," says Richard Elbein, CEO of the Alzheimer's Association-Houston & Southeast Texas Chapter. "Until we achieve that goal, we will continue to support research and dementia care. We are thrilled to partner once again with Baylor College of Medicine and their physician leaders, who will educate Houstonians about the landscape of dementia research and care."

To register, click here http://bit.ly/ALZUPDATE2023 or call 800-272-3900.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.